Stock A321550 TIUMBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart TiumBio Co., Ltd.

Equities

A321550

KR7321550006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
7,080 KRW -1.80% Intraday chart for TiumBio Co., Ltd. +1.29% -27.53%
May. 08 TiumBio Co., Ltd. Announces Positive Topline Data from Phase 2A Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain CI
Mar. 26 Tiumbio Co., Ltd. Submits CTA for Phase 1B Clinical Trial of TU7710, A Long-Acting Recombinant Activated Factor VII, in Hemophilia A or B Patients CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TIUMBIO CO., LTD.
Bio Therapeutic Drugs
-1.80%+1.29%-27.53%-31.92% - 137M - - -
  1. Stock Market
  2. Equities
  3. A321550 Stock
  4. Charts TiumBio Co., Ltd.
  5. Relative Strength Chart